The Latest Breaking News from diabetes

A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results

A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.

Medical Daily · Jul 9

1 in 4 Adults with Type 2 Diabetes Has Significant Hearing Loss, Major Review Finds

A new meta-analysis finds 1 in 4 adults with type 2 diabetes has significant hearing loss. Researchers call for routine hearing tests in standard diabetes care.

Medical Daily · Jul 9

Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase

Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to insulin initiation, which is often delayed in India. The Indian insulin market is projected to grow significantly in…

The Economic Times · Jul 9

From maternal health to influenza rates, gaps in CDC’s public health data are creating dangerous blind spots for disease tracking and prevention

Public health relies on data – whether it is tracking the effectiveness of a given year’s flu vaccine, monitoring blood lead levels around the country or estimating the prevalence of diabetes. This data forms the basis for decisions such as whether a community should expand screening for diabetes and which…

The Conversation · Jul 8

Diabetic Retinopathy: Why Eye Damage from Diabetes Shows No Symptoms Until Vision Is Already Gone

The Eye Bleeds Before You Know ItDiabetes does not attack the eye the way an infection does, with pain, redness, and urgency. It works on the tiny blood vessels at the back of the eye, the retina, over months and years. High blood sugar makes those vessel walls weak and…

Times Life · Jul 8

Men’s average testosterone levels have halved in last 50 years, say scientists

Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes

The Guardian - UK · Jul 7

The FDA Just Approved the First Inhaled Mealtime Insulin for Children

FDA approved Afrezza inhaled insulin for children ages 6+ in May 2026. No needle required at mealtimes. Here's what INHALE-1 found and what families should know.

Medical Daily · Jul 7

If You Take Ozempic, Wegovy, or Zepbound, Your Risk of Heat Illness Is Higher This Summer

GLP-1 drugs like Ozempic and Wegovy suppress thirst, raising dehydration risk in heat. Doctors say patients must hydrate proactively. Here's the specific clinical warning for summer.

Medical Daily · Jul 6

Indian scientists recreate key human placenta functions on a chip

Indian researchers have unveiled a groundbreaking "placenta-on-chip" technology, a lab-grown model replicating crucial functions of the human placenta. This innovative platform, developed by ICMR-NIRWoH and IIT Bombay, promises to unravel mysteries surrounding pregnancy, aid in understanding complications like gestational diabetes, and evaluate drug safety, potentially reducing reliance on animal testing.…

The Economic Times · Jul 4

Study Finds Dementia Risk Factors Hit Women Harder – High Blood Pressure, BMI and Hearing Loss Are Key

As researchers continue searching for ways to reduce dementia risk, a new study is shedding light on why women may face a greater burden than men. Scientists found that several well-known risk factors—including high blood pressure, elevated body mass index (BMI), hearing loss, and diabetes—appear to have a stronger negative…

Budget and the Bees · Jul 3